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Abstract
Molluscum Contagiosum Virus (MCV) is an obligate human, tumorigenic
poxvirus which causes benign skin neoplasms. Reduced inflammation during an MCV
infection has been attributed to production of MCV immune evasion molecules (IEMs).
IEMs antagonize host immune responses allowing MCV to evade the host immune
system and reprogram the host cell for viral growth. MCV IEMs alter apoptosis (MC159,
MC160), deregulate the cell cycle targeting retinoblastoma (MC007), and produce a
chemokine homolog (MC148). Bioinformatics analysis identified MC163, as another
potential host-interacting protein. Further analysis of MC163 resulted in the identification
of a mitochondrial localization sequence, putative superoxide dismutase (SOD)-like
Cu2+/Zn2+ metal binding domain, a transmembrane domain and a large C-terminal
domain that contains no identified homology to other viral or host proteins. Confocal
microscopy was utilized to verify the predicted mitochondrial localization. MC163 was
detected at the mitochondria, whereas a truncated MC163 lacking the mitochondria
localization sequence was diffused throughout the cell. Mitochondria are important
moderators in apoptotic and anti-viral signaling. Many viral proteins that localize to the
mitochondria affect mitochondria immune signaling pathways such as apoptosis.
Preliminary data suggests that expression of MC163 inhibits TNF-induced mitochondrial
membrane permeabilization MMP. Therefore, MC163 expression may contribute to
MCV immune evasion by antagonizing apoptotic signaling events.

ix

Introduction
Molluscum Contagiosum Virus (MCV), a member of the Poxviridae family,
causes benign skin lesions characterized by reduced inflammation. MCV lesions persist
for months in otherwise healthy individuals. MCV lesions are spread by skin to skin
contact, fomites, or autoinoculation and are most prevalent in children and immune
compromised individuals, such as those with HIV (Koning et al. 1994; Tyring 2003;
Mohammedamin et al. 2006). Although MCV infection is non-lethal, it causes scarring
and disfigurement which can result in emotional damage, especially in children. MCV
affects 2-10% of the world population and can account for 1% of the skin disorders in the
United States with a higher percent in children (5%) and those infected with Human
immunodeficiency virus (HIV) (5-18%) (Guan et al. 2014; Sherwani et al. 2012).
With the eradication of Smallpox, MCV remains the only poxvirus that
exclusively infects humans. In 2010, 122 million cases of MCV infection were reported,
highlighting the importance in understanding MCV infection and the development of
effective treatment strategies. Currently, there are no antiviral treatments specific for
MCV. Anti-MCV strategies rely primarily on mechanical means of removal such as
curettage and cryotherapy. However, these strategies are extremely painful for patients
suffering from chronic MCV infection and can result in suffering and anxiety, with
limited success rates. Cidofovir is available as a drug of last resort, but off target affects
limit its wide-spread use. Therefore, identification of novel anti-MCV strategies should
remain a top research priority. Unfortunately, research on MCV is hampered due to the
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inability to propagate MCV in cell culture or an animal model as well as a lack of
understanding basic MCV-host interactions.
The Poxviridae family possess large, linear dsDNA genomes. Unlike most DNA
viruses, poxviruses replicate exclusively in the cytoplasm of host cells. Therefore, to
replicate and transcribe the viral genome, members of the poxvirus family must encode
their own replication and transcription machinery. Further, by replicating inside the
cytoplasm of host cells, poxviruses are exposed to a multitude of cellular innate immune
responses (IIRs) that recognize and respond to viral infection. To combat innate immune
defenses, poxviruses devote a substantial portion of their genome to code for a variety of
host interacting proteins to modulate of cellular IIRs, such as apoptosis (Haller et al.
2014). Given that MCV persists for months in otherwise healthy individuals, it seems
reasonable to speculate that like other poxviruses, MCV must possess a myriad of
strategies to dampen host IIRs to sustain a persistent infection. Analysis of the MCV
genome revealed that MCV encodes approximately 182 proteins, 77 of which are
potential host-interacting proteins (Senkevich, et al. 1997). However, MCV host defense
strategies are extremely understudied. Of these 77 predicted host-interacting molecules,
only 7 have been characterized for function in host signal pathways. The 7 immune
modulating proteins of MCV that have been characterized are MC007, MC054, MC066,
MC132, MC148, MC159, and MC160. MC007 is a mitochondrial localizing protein that
sequesters the retinoblastoma protein (pRb) (Mohr et al. 2008). MC054 is involved in
binding Interlukin-18 (IL-18) blocking the pro-inflammatory cytokines function in innate
and adaptive immunity (Xiang et al. 2003). MC066 is a putative glutathione peroxidase

2

that blocks apoptosis induced by ultraviolet light and hydrogen peroxide (Shisler et al.
1998). MC132 inhibits NF-B activation by interaction with the p65 subunit and causes
p65 degradation (Brady et al. 2015). MC148 functions as a chemokine-like protein
binding to CxC12a and CCR8 and blocks chemotaxis (Jin et al. 2011; Luttichau et al.
2001). MC159 inhibits Tumor Necrosis factor- (TNF-), Fas, and TRAIL-induced
apoptosis and blocks activation of Nuclear Factor kappa B (NF-B) (Murao & Shisler
2005; Randall et al. 2012, Struzik et al. 2014). MC160 binds Heat Shock protein 90 and
induces I kappa Kinase (IKK) degradation resulting in the inhibition of TNF--induced
NF-B activation (Nichols & Shisler 2006; Nichols & Shisler 2009). In this study we
present evidence for a role of another MCV host-interaction protein, MC163R.
Apoptosis is a powerful antiviral response. Apoptosis can be triggered by both
extrinsic and intrinsic mechanisms. The extrinsic pathway is activated by binding of
ligands such as Fas Ligand (FasL), TNF- and TNF-related apoptosis inducing ligand
(TRAIL) to their respective receptors inducing a signal cascade that leads to the
activation of caspases and the pro-inflammatory transcription factor NF-B (Green &
Llambi 2015).
Tumor necrosis factor-alpha (TNF- is a pro-inflammatory cytokine produced in
response to a viral infection. Binding of TNF-α to its receptor can result in multiple
responses. One outcome is the activation of the host Nuclear Factor-kappa B (NF-B)
transcription factor, which leads to the transcriptional activation of NF-B regulated
genes. Once bound to the TNF R1 receptor, TNF induces the formation of a signal
complex comprised of TNF-R-associated death domain protein (TRADD), TNF-R-
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associated factor 2 (TRAF2), and receptor-interacting protein 1 (RIP1) (Li & Lin. 2007).
Subsequent recruitment of the I kappa Kinase (IKK) complex to the receptor complex
and activation of the IKK and IKK subunits causes the phosphorylation of inhibitor of
kappa B alpha (IB one of the NF-B inhibitory proteins (Chen et al. 1995; DiDonato
et al. 1997). Ubiquitination-dependent degradation of IB leads to its dissociation from
NF-B and allows for transcription of NF-B regulated genes resulting in the
transcription of pro-inflammatory mediators such as IL-6 (Li & Lin. 2007).
Alternatively, apoptosis can be induced through TNF- signaling through TNFR1 activation. Recruitment of the death-inducing signal complex (DISC) including
TRADD, RIP1 and Fas-associated death domain (FADD) leads to the recruitment of procaspase 8 and activation to its active form, caspase 8 (Micheau & Tschopp 2003).
Caspase 8 leads to the activation of the intrinsic apoptosis pathway through the cleavage
of BH3 interacting-domain death agonist (Bid) and activation of effector caspases 3 and 7
(Elmore et al. 2013). Additionally, caspase 8 can directly activate a caspase cascade by
activating effector caspases 3 and 7 (Kiraz et al. 2015). A summary of the TNF-
signaling pathway can be found in figure 1.
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Figure 1: Tumor necrosis factor alpha (TNF- Signal Pathway. Activation of the TNF-induced response occurs after TNF-binds its receptor. Recruitment of TRADD,
TRAF2 and RIP1 to the TNF-receptor lead to activation of NF-B and promote cell
survival and inflammation, whereas, recruitment of the TRADD, FADD, RIP1 and
procaspase 8 lead to apoptosis. TNF-, tumor necrosis factor alpha; TNF-R1, TNFreceptor 1; TRADD, TNF-associated death domain; TRAF2, TNF receptor-associated
factor 2; RIP1, receptor-interacting protein kinase 1; FADD, Fas-associated death
domain; Bid, BH3 interacting-domain death agonist; IKK, Inhibitor of kappa B alpha;
IKKInhibitor of kappa B betaNF-B, Nuclear factor kappa B; ROS, reactive oxygen
species.
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During a viral infection, the intrinsic apoptotic pathway can be induced by
numerous intracellular responses, all being mediated through the mitochondria.
Mitochondrial membrane permeabilization (MMP) is the key step in apoptotic signaling
through the mitochondria and is regulated by B-cell lymphoma 2 (BcL-2) family
proteins. The BcL-2 family is comprised of three classes of proteins containing Bcl-2
homology regions (BH1-4). BCL-2 associated X protein (Bax) and Bcl-2 homologous
antagonist/killer (Bak) function as pro-apoptotic effector proteins that are activated by the
pro-apoptotic BH3 only proteins, Bid, Bcl-2-like protein 11 (Bim), p53 upregulated
modulator of apoptosis (Puma), Phorbol-12-myristate-13-acetate-induced protein 1
(Noxa) and B lymphocyte kinase (Blk). The anti-apoptotic members of the Bcl-2 family
include BcL-2, B-cell lymphoma-extra large (BcL-XL) and Induced myeloid leukemia
cell differentiation protein (McL-1). An intracellular death signal induces the activation
and oligomerization of Bax or Bak which form pores in the mitochondrial outer
membrane (MOM) allowing for the release of pro-apoptotic factors from the intermitochondrial space including cytochrome c, apoptotic protease activating factor 1
(Apaf1), and the second mitochondria-derived activator of caspases/ direct inhibitor of
apoptosis-binding protein with low pI (SMAC/Diablo) (Kiraz et al. 2015; Upreti et al.
2008). Cytochrome c binds to Apaf1 and recruits caspase 9 to form what is known as the
apoptosome (Yuan et al. 2013). Apoptosis occurs by the activation of effector caspases 3,
6 and 7 (Kiraz et al. 2015). SMAC/Diablo antagonizes anti-apoptotic inhibitors of
apoptosis (IAP) proteins thus removing the inhibition on the formation of the apoptosome
(Green & Llambi 2015; Kiraz et al. 2015). The intrinsic and extrinsic pathways are not
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mutually exclusive wherein activation of one pathway typically leads to secondary
activation of the other pathway. An alternative activation of the intrinsic pathway is
through Bid cleavage by caspase 8 which leads to MMP activated by extrinsic apoptotic
signals initiated at the TNF family receptors (Kiraz et al. 2015).
Poxviruses encode numerous viral BcL-2-like proteins (vBcL-2) that function to
antagonize and modulate the apoptotic signal induced by host death response
mechanisms. VACV contains at least 5 vBcL-2 proteins that all function to modulate
various aspects of apoptosis at the mitochondria (Boya et al. 2004). So far, no equivalent
proteins have been found in MCV.
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Figure 2: Intrinsic Apoptosis Pathway: Pro-apoptotic stimuli cause the permeabilization
of the mitochondrial outer membrane causing the release of pro-apoptotic factors
including SMAC and cytochrome c. SMAC binds IAP allowing for the activation of
caspase 9 and caspase 3. Cytochrome c binds Apaf1 and recruits caspase 9 to form the
apoptosome which activates the effector caspase 3 leading to apoptosis. Bid, BH3
interacting-domain death agonist; Bax, BCL-2 associated X protein; Cyt c, cytochrome c;
BcL-2, B-cell lymphoma 2; Apaf1, apoptotic protease activating factor 1; IAP, inhibitor
of apoptosis; SMAC, second mitochondria-derived activator of caspases; DNA,
deoxyribonucleic acid; ER, endoplasmic reticulum.
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Another pathway that is activated in response to a viral infection is the MAVS
signaling pathway in which over-expression of the MAVS protein has been shown to
induce apoptosis (Lei et al. 2009). MAVS mediated signaling involves the recruitment of
Heat-shock protein 90 (HSP90), the IKK complex (Inhibitor of nuclear factor kappa-B
kinase (IKK) alpha, -beta and -epsilon (IKK and TANK binding kinase 1
(TBK1) which elicit the production of INF’s through activation of the interferon
regulatory factor 3 (IRF3) and NF-B transcription factors (Huang et al. 2014; Amaya et
al. 2014). Viral modulation at the MAVS complex has been shown with MC159
interactions blocking TBK1 signaling through the direct interaction with TBK1 and
MC160 preventing TBK1 activation through a still undetermined mechanism (Randall et
al. 2013). If the MAVS complex is disrupted, Bax is imbedded into the mitochondrial
membrane causing MMP and subsequent activation of apoptosis (Chattopadhyay et al.
2010). Another signal pathway mediated by MAVS is through the recruitment of FADD
and Pro-caspase 8 which mediates apoptosis similar to the activation of apoptosis through
extrinsic signals (Maadidi et al. 2014).
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Figure 3: MAVS-induced Apoptosis Pathway. Activation of the MAVS-induced antiviral
response occurs downstream of cellular danger sensors. Recruitment of Hsp90, TBK1
and IKK to the MAVS complex lead to activation of transcription factors (NF-B,
IRF3) and promote cell survival, inflammation and the production of interferon’s,
whereas, recruitment of the Hsp90, FADD, and procaspase 8 lead to apoptosis. MAVS,
mitochondrial antiviral signaling protein; HSP90, Heat-shock protein 90; FADD, Fasassociated death domain; Bid, BH3 interacting-domain death agonist; TBK1, TANK
binding kinase 1; IKKe, Inhibitor of nuclear factor kappa-B kinase epsilon; Bax, BCL-2
associated X protein; IRF3, ; NF-kB, Nuclear factor kappa B; IFN, Interferon; MMP,
mitochondrial membrane permeabilization.
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Lack of a cell culture or animal model to study MCV severely hampers efforts to
understand MCV immune evasion strategies. Current efforts to understand MCV
pathogenesis are being done studying primary lesions and the use of a luciferase reporter
based system, but this approach can lead to experimental difficulties resulting from MCV
strain variations and large differences in viral yields between lesions (Sherwani et al.
2012). The approach taken in this report was to isolate a particular gene product of MCV
and to study the role on apoptotic processes in vitro by transient transfection. The
advantages of this system are the relative ease of implementation and the wide range of
studies that can be done relatively quickly. The downside is that all of the results need to
be taken with the understanding that the results obtained here may or may not represent
what would be seen in an actual viral infection. A more detailed review of current
strategies for studying MCV can be found in Shisler 2015.
The purpose of this thesis was to characterize a novel MCV protein, MC163, and
determine its role in the modulation of apoptosis. Bioinformatics analysis of the MC163R
ORF revealed a mitochondrial localization sequence (MLS), a metal binding domain and
a putative transmembrane domain. Since all viral proteins that localize to the
mitochondria have a role in the modulation of death pathways, the working hypothesis is
that MC163 modulates apoptosis. Mutants of MC163R were made by splitting the full
length protein at a predicted protease site. A mutant lacking the MLS could give valuable
clues as to the function and role of MC163R in apoptosis. The role of MC163 in
apoptosis was assessed by JC-1 staining as an indicator of mitochondria membrane
permeabilization, a hallmark in both extrinsic and intrinsic apoptosis pathways.
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Materials and Methods
Expression vectors for MC163R Mutants:
To construct the C-terminal mutant plasmid, the MCV genomic plasmid library (a gift
from Dr. Joachim J. Bugert) containing ORF MC163R was amplified by PCR using the
forward primer MC163Pr3For, 5'- TTT TC GAATTC G CCA TGT TGT CGC CGG
CGG AC-3', containing the EcoRI restriction site (underlined), and reverse primer,
MC163.HARev1, 5'- GTC ATA CGG GTA CAG CGC GCC CTC CG -3', containing the
first half of the HA tag. Subsequent PCR was done to add the second half of the HA
oligonucleotide sequence using the forward primer MC163Pr3For, and the reverse
primer, MC163.HARev2, 5'- AAT TCTAGA TTA GGC ATA GTC CGG CAC GTC
ATA CGG GTA C -3', containing the XbaI restriction site (underlined). The amplified
sequence was digested using EcoRI/XbaI cloned into the pCI vector (Promega). Multiple
attempts were made to clone the N-terminal and full length MC163 constructs. However,
the high GC rich content in the upstream region of MC163R made cloning the N-terminal
portion difficult. To circumvent this problem, the N-terminal region of MC163R
(MC163N, a.a. 1-132) was codon optimized and synthesized in vitro by GenScript and
inserted into pcDNA3.1-HA. To construct the full length MC163R plasmid, overlapping
PCR was used by amplifying the N-terminal portion from the synthesized MC163N
construct by PCR using the forward primer MC163NGSFor, 5'- TCC GAA TTC GCC
ACC ATG GGA CCA AGA G-3', and reverse primer, MC163NGS Rev, 5'- GGC TCG
CTA TGG TTC CAG AAG ACC TGC CTC TCC AG-3'. The C-terminal portion was
amplified from the MC163C/pCI construct made previously by PCR using the forward

12

primer, MC163C_For, 5'- GAG AGG CAG GTC TTC TGG AAC CAT AGC GAG CCT
C-3', and the reverse primer, MC163.CRevHA2. The N-terminal and C-terminal
sequences were PCR amplified using MC163NGSFor and the reverse primer MC163 to
generate the full length MC163 construct,.CRevHA2. All constructs were engineered to
contain a C-terminal HA-tag. Constructs were cloned into the pCDNA3.1 vector and
sequenced (Genewiz) to verify the correct nucleotides. PCR conditions used can be found
in Table 3.
Plasmid DNA preparations:
Plasmid DNA was isolated from bacterial cultures using the PureYield Plasmid
Miniprep system (Promega) according to the manufactures protocol. Briefly, bacteria
(DH5α, TOP10, BL-21) harboring plasmid inserts containing experimental constructs
were grown for 16-20 hours in Luria broth supplemented with the proper antibiotic
(ampicillin, 100 g/mL, Life Technologies; kanamycin, 50 g/mL). Bacteria were
harvested by centrifugation at 14,000 rpm for 1 minute, resuspended in 600mL of TrisEDTA buffer (TE) and the Promega protocol was followed. Plasmid DNA was eluted in
TE buffer, assessed for purity and concentration using a Nanovue Plus spectrophotometer
and stored at 4oC. OD260/OD280 values of 1.8-2.0 were deemed acceptable and utilized in
subsequent experiments.
Cell culture and Transfections
Human embryonic kidney 293T (HEK 293T) and HeLa cells were maintained in
Dulbecco’s modified eagle medium (DMEM, Sigma or HiMedia) supplemented with
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10% fetal bovine serum and 1% penicillin-streptomycin (Sigma) at 37oC, with 5% CO2 in
a humidified incubator. Stable transfected HeLa cell lines (HeLa-163F, HeLa-163C,
HeLa-163N) were maintained as described above with the addition of the selection
marker, G-418 (Life Technologies, 1mg/mL) to the growth media. Transfection of
HEK293T cells or HeLa cells was performed using Mirus Trans-IT 2020 reagent in OptiMEM (Gibco/Life Technologies) at 3 L/g or 2 L/g of total DNA, respectively.
Immunoblotting
HEK293T cells or HeLa cells were harvested using RIPA lysis buffer
supplemented with protease inhibitor cocktail added according to the manufactures
recommended concentration (Amresco, M250: AEBSF, Aprotinin, E-64, Bestatin,
Leupeptin, Pepstatin) and assayed for total protein content using the BCA assay (Pierce)
for total protein according to the manufactures protocol (Thermo Scientific). Samples
were boiled for 5 minutes with 5% 2-mercaptoethanol in sodium dodecyl sulfate (SDS)
sample buffer (62.5 mM Tris pH 6.8, 2% SDS, 10% Glycerol, 100 mM DTT, 0.01%
bromophenol blue) and placed on ice until use. Lysates were resolved by 10% SDSPAGE, transferred to polyvinylidene difluoride (PVFD) membranes (Millipore), blocked
in 5% milk (Carnation non-fat dry milk) in 1X Phosphate-buffered saline with Tween®
20 (PBST, 50 mM Tris.HCl, pH 7.4, 150 mM NaCl, 0.1% Tween 20) for 30 minutes and
probed for 1 hour using the appropriate antibody (-HA, 1:2,500; -PARP-1, 1:1,250; FLAG, 1:2,500) diluted in 0.5% milk in TBST. The PVDF membranes were washed
three times with 0.5% milk in TBST then incubated with secondary antibodies (goat--

14

mouse-HRP, 1:10,000; goat--rabbit-HRP, 1:10,000; HRP, horseradish peroxidase) for 1
hour, washed three times with 0.5% milk in TBST then visualized using SuperSignalTM
West Pico or SuperSignalTM West Femto (Thermo Scientific) chemiluminescent reagent
according to manufactures instruction. Blots were visualized using a FluorChem E
imaging system (Protein Simple).
JC-1 Staining for Detection of Mitochondrial Membrane Permeabilization
Subconfluent HeLa cells were transfected with either pCDNA3.1 (500 ng); pHAMC159 (500 ng), pHA-MC163F (500 ng), pHA-MC163N or pHA-MC163C (500 ng).
Twenty four hours later cells were treated with TNF- (10 ng/mL) and cyclohexamide
(CHX, 10 ng/mL) or CCCP (Carbonyl cyanide m-chlorophenyl hydrazone, 100M) and
incubated at 37oC for 6 hours (TNF-) or 30 minutes (CCCP) in a 5% CO2 humidified
incubator. Cells were stained with JC-1 (5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide, Cayman Chemical, 1 M ) and incubated in a 5% CO2
incubator at 37oC for 20 minutes in the dark. Immediately after incubation, the cells were
analyzed by confocal microscopy (Olympus, Monomer detection: Ex/Em = 514 nm/529
nm, J-aggregate detection: Ex/Em = 585 nm/590 nm). Multiple images were taken for
each condition using constant voltage settings and analyzed with ImageJ software using
the Fiji image processing package (Schindelin, et al. 2012). Composite images were split
into separate color channels, binarized and analyzed for % area for each color. The ratio
of J-aggregate to monomer form of JC-1 was calculated and normalized to the control.
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This experiment was repeated 5 times (n=5) with a minimum of 3 images taken for each
condition in each experiment.
Lucerifase Assay
HEK293T cells were plated at 2.5 x 105 cells per well in a 12-well plate and
grown for 24 hours at 37oC in a 5% CO2 humidified incubator. After 24 hours, the cells
were transfected with 500 ng of plasmid DNA (pCDNA3.1, pHA-MC159, pHAMC163F, pHA-MC163C or pHA-MC163N), 225 ng reporter plasmids (200 ng pNF-kBLuciferase or pIFN-b-luciferase, 25 ng pRenilla TK) and 275 ng of pCDNA3.1 using
Mirus Trans-IT 2020 reagent (Mirus) at a ratio of 3 L/g of total DNA. The cells were
then incubated for another 24 hours at 37oC in a 5% CO2 incubator prior to treatment
with 10 ng/mL TNF-α. 6-8 hours? post treatment, the cells were lysed at room
temperature for 30 minutes with 1X passive lysis buffer (Promega) supplemented with
protease inhibitors added according to manufactures recommended concentration
(Amresco, M250: AEBSF, Aprotinin, E-64, Bestatin, Leupeptin, Pepstatin). The lysates
were assayed for firefly and sea pansy luciferase activity using the Dual-reporter assay
according to manufactures instructions (Promega). Statistical significance was
determined by utilizing the student’s t-test.
Immunofluorescence and confocal microscopy for localization of MC163R mutants:
HEK293T cells or HeLa cells were plated at 2.5 x 105 cells per well on glass
coverslips in a 12-well plate and grown for 24 hours at 37oC in a 5% CO2 humidified
incubator. After 24 hours, the cells were transfected with 1 µg of plasmid DNA
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(pCDNA3.1, pHA-MC163F, pHA-MC163C or pHA-MC163N) and 500 ng
pmTurquoise2-Mito [pmTurquoise2-Mito was a gift from Dorus Gadella (Addgene
plasmid # 36208))] using Mirus Trans-IT 2020 reagent (Mirus) at a ratio of 3 L/g
(HEK293T) or 2 L/g (HeLa) of total DNA. The cells were then incubated for another
24 hours at 37oC in a 5% CO2 incubator prior to fixation with 4% paraformalyhyde
(Mpbio) for 1 hour at 4oC. Cells were rinsed twice with PBS, permeabilized with 0.5%
Triton X-100 for 5 minutes, rinsed with PBS twice, incubated with 50 mM glycine for 10
minutes then blocked with 5% milk (Carnation non-fat dry milk) in 1X Phosphatebuffered saline with Tween® 20 (PBST, 50 mM Tris HCl, pH 7.4, 150 mM NaCl, 0.1%
Tween 20) for 30 minutes. To detect MC163R mutants, the cells were incubated with an
anti-HA (Sigma Aldrich) conjugated to an Alexa FluorTM 647 dye (Thermo Fisher
antibody labeling kit) for 1 hour at 18-22oC, rinsed three times with 0.5% milk in PBST
for 10 minutes, rinsed twice with PBST for 15 minutes then mounted to microscope
slides with 50% glycerol in PBS. The plasmid pmTurquoise2-Mito encodes a cyanfluorescent protein that localizes to the mitochondria (Stetten, et al. 2012). Fluorescence
was detected using an Olympus microscope (software) for pmTurquoise2-Mito (Ex = 488
nm, Em = 519 nm) and MC163R mutants (Ex = 633 nm, Em = 671 nm). Images were
false colored using Olympus Fluoview software and exported as JPEG files for each of
the fluorescence signals.
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Results
Cloning the MCV MC163 Gene:
The goal of our research was to identify novel MCV immune evasion molecules.
MC163R was previously reported to contain a putative Cu2+/Zn2+ binding domain (REF;
amino acids (a.a.) 46-108, Figure 4). Our bioinformatics analysis revealed the presence of
a mitochondrial localization sequence (MLS) located in the N-terminus portion of
MC163R (a.a. 1-30, (http://psort.ims.u-tokyo.ac.jp/) and a putative transmembrane
domain (TMD, a.a. 109-132,) immediately downstream of the predicted metal binding
domain (a.a. 30-46) (http://www.ch.embnet.org/software/TMPRED_form.html). The
predicted TMD is flanked by positively charged amino acids similar to other
mitochondrial outer membrane (MOM) proteins anchored by the N-terminus, for
example, Tom70 (translocase of the outer mitochondrial membrane 70) (Rapoport, D.,
2003; Figure 6). Further analysis of the C-terminal portion of MC163R identified no
regions of homology in the amino acid sequence to other viral or host proteins. MC163R
protein folding representations using Phyre2 server and iTasser prediction website,
respectively, can be seen in Figure 7. MC163R contains a GC rich upstream region which
made cloning of this gene particularly difficult. To circumvent this problem the NTerminal portion of MC163R (MC163N, a.a. 1-132) was synthesized in vitro, while the
C-terminal region (MC163C, a.a. 132-620) was cloned using PCR (Figure 5, Table1,
Table 2). The synthesized MC163N construct was codon optimized (Figure 8) to remove
high GC content, but maintained the wild-type amino acid sequence (Figure 9).
Overlapping PCR was used to generate the full length construct (MC163F, a.a. 1-620)
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(Figure 5, Table 1, Table 2). All constructs were engineered to contain a C-terminal HA
epitope tag to detect expression. PCR amplicons were cloned into the pCDNA3.1 vector
and sequenced. Expression of the constructs in HEK293T cells was verified by
immunoblotting and detection with anti-HA antibodies (Figure 10A). Both the MC163F
and MC163C were easily detected at 67 kD and 50 kD respectively. We also detected a
50 kD product in the MC163F lanes corresponding to a predicted cleavage site in
between the N- and C-terminal MC163 constructs. Relative to MC163F and MC163C,
MC163N expressed at lower levels, but was detected as a band of approximately 17 kD
with longer exposure time (Figure 10B).
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Figure 4: Representation of domains predicted by bioinformatics in MC163R.
Mitochondrial localization sequence was identified using ipSORT prediction website
(Bannai et al. 2001; Bannai et al. 2002) and TargetP 1.1 Server (Emanuelsson et al. 2000)
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Figure 5: MC163R mutants characterized in this study. Full length, a.a. 1-620; N-terminal
mutant, a.a. 1-132; C-terminal mutant, a.a. 132-620
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A)
MC163R (MCV)
TOM 70 (H.s.)

RHGRAPRR LALTAPLPLLLLPLLLPPMILLFF LSPADAKPVLER
PRWQ LALAVGAPLLLGAGAIYLWS
RQQRRREARGR

B)
Metal Binding Domain
MC163R (MCV) EHGYAHTHTCEDTPAKEHGHLGEHECLRGHGHAHAYEERCENKHKHLHAHEHTHERHGRAPRR

C)

Figure 6: Amino acid sequence of the predicted transmembrane domain and Metal
Binding domain of MC163R. A) The N-terminal portion of MC163R contains a
hydrophobic sequence flanked by positively charged amino acids similar to TOMM70, a
mitochondrial outer membrane (MOM) resident protein. Hydrophobic sequence is
underlined, Bold indicate positive charged amino acids. MCV, Molluscum Contagiosum
virus, H.s., Homo sapiens. B) Histidine rich metal binding domain of MC163R (a.a. 46108). C) Amino acid alignment of MC163R and HHSV-8 K7 protein.
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Figure 7: MC163F protein folding predictions using Phyre2 (A) and iTasser (B-F)
predictions. Blue, Mitochondrial localization sequence; Yellow, Metal binding domain;
Red, Transmembrane domain; Grey, C-terminal domain.
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Primer Name:

Primer Sequence:

MC163Pr3For

5'- TTT TCG AAT TCG CCA TGT TGT CGC CGG CGG AC-3'

MC163C_For

5'- GAG AGG CAG GTC TTC TGG AAC CAT AGC GAG CCT C-3'

MC163NGSFor

5'- TCC GAA TTC GCC ACC ATG GGA CCA AGA G-3'

MC163.HARev1

5'- GTC ATA CGG GTA CAG CGC GCC CTC CG -3'

MC163.HARev2

5'- AAT TCT AGA TTA GGC ATA GTC CGG CAC GTC ATA CGG GTA C -3'

MC163NGS Rev

5'- GGC TCG CTA TGG TTC CAG AAG ACC TGC CTC TCC AG-3'

Table 1: Polymerase chain reaction primer sequences used for cloning MC163R Mutants.
Primers MC163Pr3For, MC163.HARev1 and MC163.HARev2 were used to clone the Cterminal mutant into the pCI vector. Primers MC163NGSFor and MC163NGSRev were
used to produce the N-terminal portion of the full length clone with MC163C_For and
MC163.HARev2 to produce the C-terminal portion. Overlapping PCR was used to create
the full length clone using the MC163NGSFor forward primer and the MC163.HARev2
reverse primer.
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Mutant

Vector backbone

Forward Primer

Reverse Primer

MC163C

pCI

MC163Pr3For

MC163.HARev1, MC163.HARev2

MC163C

pCDNA3.1

MC163C_For

MC163.HARev2

MC163N

pCDNA3.1

MC163NGSFor

MC163NGS Rev

MC163F

pCDNA3.1

MC163NGSFor

MC163.HARev2

Table 2: Polymerase chain reaction primers used to construct MC163 Mutants.
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Figure 8: DNA sequence comparison of wild type MC163N vs GenScript codon
optimized MC163N.
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Figure 9: The protein alignment for wild-type MC163N and codon optimized MC163N
(GenScript). Amino acid sequence comparison shows the codon optimized DNA
sequence maintains the wild-type amino acid sequence.
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67kD
50kD

*
*

17kD
MC163-

F

N

C

Figure 10: The expression of MC163R mutants by immunoblotting. A) MC163F and
MC163C were readily detected. MC163N, however, expressed at weaker levels then
MC163F and MC163C and additional detection time was required to observe MC163N
(*).
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The N-terminal portion of MC163 is required for mitochondrial localization
To determine the localization of the MC163R constructs, HeLa cells were cotransfected with the indicated MC163R construct and pmTurquise2Mito, a cyan
fluorescent protein engineered to contain a mitochondrial localization sequence
(Goedhart, J., et al, 2012). For detection of MC163R constructs, HeLa cells were
incubated with an anti-HA antibody conjugated to an Alexa Fluor 647 dye to ensure that
no overlap was seen between the two detection channels. The excitation and emission
spectra for pmTurquise2Mito is Ex/Em = 488 nm/519 nm and the anti- HA antibody
conjugated to Alexa Fluor™ 647 dye is Ex/Em = 633 nm/671 nm. Both MC163F and
MC163N contain the mitochondrial localization sequence and were readily detected to
co-localize with the mitochondrial marker pmTurquise2Mito (Figure 11, Top and Bottom
panels). MC163C, however, which lacks both the MLS and the putative transmembrane
domain, did not localize to the mitochondria, but was detected in a diffuse staining
pattern throughout the cell (Figure 11, Middle panel). It is worth noting that the deletion
of the entire C-terminal region of MC163 did not affect the localization of the N-terminal
(MC163N) mutant. Therefore, we conclude the N-terminal portion of MC163R is
required for mitochondrial localization.
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F

C

N

pmTurq2Mito

MC163 Mutant

Merge

Figure 11: Localization of MC163R mutants. Mitochondrial localization was confirmed
for MC163F and MC163N mutant (Top and Bottom panels). MC163C mutant does not
localize to the mitochondria (Middle panels). Colocalization was done with a
mitochondria localizing fluorescent protein, pmTurquise2Mito (green). MC163R mutants
were labeled using an-HA antibody conjugated with an Alexa Flour 647 (HA:AF647) dye. Images were acquired using an Olympus confocal microscope
(pmTurquise2Mito: Ex/Em = 488 nm/519 nm; -HA:AF647: Ex/Em = 633 nm/671 nm)
and processed using Olympus FluoView Ver4.2 software. Co-localization events are
depicted with white arrows. F, MC163F; C, MC163C; N, MC163N.
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MC163R inhibits TNF--induced mitochondrial membrane permeabilization
As of the date of this report, all viral proteins that localize to the mitochondria
have been shown to modulate cellular death pathways. Therefore, the working
hypothesis was that MC163R dampens the extrinsic apoptotic pathway. To examine the
effect of MC163R on mitochondrial membrane permeabilization (MMP) we utilized the
cationic dye JC-1. JC-1 forms J-aggregates in the mitochondria that fluoresce with an
emission maximum at 590 nm and also forms monomers when diffuse in the cytoplasm
with an emission maximum at 529 nm. Treatment with TNF- induces MMP and can be
seen as a shift from J-aggregate to monomer JC-1 which can be detected by confocal
microscopy. Treatment with TNF- (10ng/mL) and cycloheximide (CHX, 10ng/mL)
induced MMP in cells transfected with empty vector and was detected by the loss of the
J-aggregate JC-1 signal (Figure 12). In contrast, cells expressing pHA-MC159, an MCV
protein that antagonizes both Fas and TNF-induced apoptosis by binding FADD and
procaspase-8 (Thome et al. 1997; Shisler & Moss 2001; Nichols & Shisler 2009), were
protected from MMP (Figure 12). Cells expressing MC163F and MC163N were
protected from TNF--induced MMP similar to MC159. In contrast, cells expressing
MC163C, which lack the ability to localize to the mitochondria, resulted in the loss of the
mitochondria membrane potential and subsequent MMP similar to cells expressing empty
vector alone (Figure 12). The results were quantified using ImageJ software using the Fiji
image processing package (Schindelin, J., et al., 2012). The ratio of J-aggregate to
monomer form of JC-1 was calculated and normalized to the control. TNF- treatment of
cells expressing vector alone resulted in a shift from J-aggregate to monomer JC-1
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indicating a loss of mitochondrial membrane potential and MMP. In contrast, the Jaggregate to monomer ratio of MC159, MC163F and MC163N expressing cells remained
unchanged after TNF-/CHX treatment, whereas MC163C expressing cells resulted in a
shift in the J-aggregate to monomer ratio similar to vector alone (Figure 13). Taken
together, our data indicates that the N-terminal region of the MC163R protein is required
to prevent MMP induced by TNF-.
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Figure 12: TNF--induced MMP: Mitochondrial membrane permeabilization (MMP)
detected by JC-1 staining of HeLa cells with and without TNF- treatment (10ng/mL, 6
hours). J-aggregate channel is shown (detection: Ex/Em = 585 nm/590 nm).
Subconfluent HeLa cells were transfected with pCDNA3.1 (500 ng); pHA-MC159 (500
ng); pHA-MC163F (500 ng); pHA-MC163N; or pHA-MC63C (500 ng) then stained with
cyanine dye JC-1 (5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimi- dazolylcarbocyanine
iodide, Cayman Chemical) for 20 minutes then immediately imaged using an Olympus
confocal microscope. J-aggregate channel is shown (detection: Ex/Em = 585 nm/590
nm). Untreated HeLa cells transfected with pCDNA3.1 (A); pHA-MC159 (C); pHAMC163F (E); pHA-MC163N (G) and pHA-MC163C (I). MMP in pCDNA3.1 transfected
cells (B). No MMP in positive control (pHA-MC159, D). MC163F and MC163N block
MMP induced by TNF- treatment (F, H) MC163C does not block MMP (J). Images
represent the J-aggregate form of JC-1 and are shown from one representative
experiment, (n=5).
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Fold Change J-aggragate/monomer JC-1
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Figure 13: The effect of MC163F on the mitochondrial membrane permeabilization
induced by TNF- treatment. Subconfluent HeLa cells were transfected with pCDNA3.1
(500 ng); pHA-MC159 (500 ng), pHA-MC163F (500 ng), pHA-MC163N or pHAMC163C (500 ng). Twenty four hours later cells were treated with TNF- (10 ng/mL)
and cyclohexamide (CHX, 10 ng/mL) and incubated at 37oC for 6 hours in a 5% CO2
humidified incubator. Cells were stained with the cyanine dye JC-1 (5,5′,6,6′-tetrachloro1,1′,3,3′-tetraethylbenzimi- dazolylcarbocyanine iodide, Cayman Chemical) for 20
minutes then immediately imaged using an Olympus confocal microscope (Olympus,
Monomer detection: Ex/Em = 514 nm/529 nm, J-aggregate detection: Ex/Em = 585
nm/590 nm). Multiple images were taken for each sample (minimum = 3 images /
sample) and analyzed with ImageJ software using the Fiji image processing package
(Schindelin, J., et al. 2012). Values represent the ratio of J-aggregate to monomer form of
JC-1 normalized to the control and are shown from one representative experiment, (n=5)
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as mean +/- standard deviations (SD). Significant differences between MC163F,
MC163N, MC159 and vector control were determined by two-tailed t-test with
significance (*) = P < 0.01, (**) = P < 0.001.
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MC163R modulates NF-B activation induced by TNF-
In addition to TNF-induced apoptosis, treatment with TNF-a can induce
activation of NF-B. NF-B is activated by numerous factors including viral infection
and modulates the inflammatory response through the transcription of pro-inflammatory
cytokines (TNF-, IL-1, IL-6, IL-12) and immune regulatory molecules (MHC I, TCR,
) (Oeckinghaus & Ghosh 2009). Viral regulation of NF-B is a key component to
immune evasion. MCV encodes three proteins, MC132, MC159 and MC160, which have
been shown to block the activation of NF-B through different mechanisms targeting the
same pathway (Brady et al. 2015; Murao & Shisler 2005; Randall et al. 2012; Struzik et
al. 2014; Nichols & Shisler 2006; Nichols & Shisler 2009). Seeing that another poxvirus,
Vaccinia virus (VACV) encodes multiple proteins that modulate NF-B, it is reasonable
to assume that MCV might also encode additional proteins to block NF-B activation
(Bahar et al., 2011; Smith et al., 2013). Therefore, we tested if MC163R expression might
also affect TNF--induced NF-B activation. HEK293T cells were transfected with
either empty vector, pHA-MC160, pHA-MC159, or pHA-MC163F as well as pNK-B
firefly luciferase and pRL-null Renilla luciferase. In cells transfected with empty vector,
treatment with TNF- resulted in a significant increase in the levels of NF-B activation
as detected by an increase in firefly luciferase values. Expression of both HA-MC160 and
HA-MC159 dampened TNF-induced NF-B regulated luciferase activity consistent with
previous results (Murao & Shisler 2005; Nichols & Shisler 2009). Interestingly HA-
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MC163F expressing cells resulted in a two-fold decrease in the relative activation of NFB relative to cells transfected with empty vector after TNF- treatment (Figure 14).
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Figure 14: The effect of MC163F on the activation of NF-B induced by TNF-
treatment. Subconfluent HEK293T cells were transfected with reporter plasmids (pNFB-lucerferase, (225ng); pRL-null Renilla, (25ng)); pCDNA3.1 (500ng); pHA-MC160
(500ng), pHA-MC159 (500ng) and pHA-MC163F (500ng). Twenty four hours later cells
were treated with TNF- (10ng/mL, 6 hours), lysed in passive lysis buffer supplemented
with protease inhibitors and assayed for firefly and sea pansy luciferase activity. Values
represent the fold change as compared to untreated empty vector transfected cells (3.1 (-))
and are shown from one representative experiment, run in triplicate (n=3) as mean +/standard deviations (SD). Significant differences between MC163F, MC160, MC159 and
cells transfected with empty vector were determined by two-tailed t-test with significance
(*) = P < 0.001.
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MC163R inhibits CCCP-induced Mitchondrial Membrane Permeabilization
Viruses can induce cellular stress and induce apoptosis in a variety of ways. The
mitochondria are a vital component of apoptotic signaling. Given that MC163R localizes
to the mitochondria and inhibits TNF--induced mitochondrial membrane
permeabilization (MMP), MC163 might also protect cells from CCCP-induced apoptosis
as well. CCCP (carbonyl cyanide m-chlorophenyl hydrazone) is a protonophore that
induces mitochondrial stress by disrupting the proton motive force. Treatment with
CCCP (100ng/mL) induced MMP in cells transfected with empty vector and was detected
by the loss of the J-aggregate JC-1 signal (Figure 15). In contrast, cells expressing pHAMC163F were protected from MMP (Figure 15). The results were quantified using
ImageJ software using the Fiji image processing package (Schindelin et al. 2012). The
ratio of J-aggregate to monomer form of JC-1 was calculated and normalized to the
control. CCCP treatment of cells expressing vector alone resulted in a shift from Jaggregate to monomer JC-1 indicating a loss of mitochondrial membrane potential and
MMP. In contrast, the J-aggregate to monomer ratio MC163F expressing cells remained
unchanged after CCCP treatment.
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Figure 15: JC-1 staining of HeLa cells treated with and without CCCP (carbonyl cyanide
m-chlorophenyl hydrazone). Subconfluent HeLa cells were transfected with pCDNA3.1
(500 ng); pHA-MC159 (500 ng); or pHA-MC163F (500 ng). Twenty four hours later
cells were treated with CCCP (100M/mL) and incubated at 37oC for 30 minutes in a 5%
CO2 humidified incubator. Cells were stained with the cyanine dye JC-1 (5,5′,6,6′tetrachloro-1,1′,3,3′-tetraethylbenzimi- dazolylcarbocyanine iodide, Cayman Chemical)
for 20 minutes then immediately imaged using an Olympus confocal microscope. Jaggregate channel is shown (detection: Ex/Em = 585 nm/590 nm). Untreated cells
transfected with pCDNA3.1 (A) and pHA-MC163F (C). Vector control does not block
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MMP induced by CCCP treatment (B), however, MC163F does blocks MMP induced by
CCCP treatment (D).
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Figure 16: The effect of MC163F on the mitochondrial membrane permeabilization
induced by CCCP treatment. Subconfluent HeLa cells were transfected with pCDNA3.1
(500 ng); pHA-MC159 (500 ng); and pHA-MC163F (500 ng). Twenty four hours later
cells were treated with CCCP (100M/mL) and incubated at 37oC for 30 minutes in a 5%
CO2 humidified incubator. Cells were stained with the cyanine dye JC-1 (5,5′,6,6′tetrachloro-1,1′,3,3′-tetraethylbenzimi- dazolylcarbocyanine iodide, Cayman Chemical)
for 20 minutes then immediately imaged using an Olympus confocal microscope
(Olympus, Monomer detection: Ex/Em = 514 nm/529 nm, J-aggregate detection: Ex/Em
= 585 nm/590 nm). Multiple images were taken for each sample (minimum = 3 images /
sample) and analyzed with ImageJ software using the Fiji image processing package
(Schindelin, J., et al., 2012). Values represent the ratio of J-aggregate to monomer form
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of JC-1 normalized to the control and are shown from one representative experiment,
(n=3) as mean +/- standard deviations (SD).
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Discussion
In this thesis, we show that MCV contains an MC163R ORF that functions in
modulation of apoptosis through modulation of mitochondrial membrane
permeabilization (MMP). An N-terminal mitochondrial localization sequence targets
MC163R to the mitochondria. The exact mitochondrial location is yet to be determined.
MC163R possesses a hydrophobic trans-membrane domain (TMD) flanked by positively
charged residues similar to Tom70, a mitochondrial outer membrane protein (Figure 6A).
Poxvirus proteins M11L of Myxoma virus and F1L of Vaccinia virus locate to the
mitochondria, block apoptosis and contain a similar TMD (Everett et al. 2000; Stewart et
al. 2005; Boya et al. 2004). An interesting feature of MC163R is the predicted
Copper/Zinc binding domain. This type of domain is typically found in superoxide
dismutase proteins. The Myxoma virus protein M131R and Shope fibroma virus S131R
proteins modulate apoptosis through inhibition of SOD1 activity by binding to copper
chaperone proteins (Teoh et al. 2005). Interestingly, MC163R expressing cells did not
exhibit significant changes in SOD1 activity when compared to controls (data not
shown).
MC163R mutants were generated after bioinformatics analysis identified protease
sites immediately downstream of the TMD (https://prosper.erc.monash.edu.au; calpain-1,
GTLY-LIPS, a. a. 180-187; cathespsin K, QVFW-NHSE, a. a. 145-152). The cellular
cleavage product of the full length MC163R mutant was identified and can be seen in
figure 10A, 50kD band. Both the full length, MC163F and N-terminal MC163N
truncated mutants were shown to block TNF--induced mitochondrial membrane
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permeabilization (MMP) (Figure 13). In contrast, the MC163C mutant loses its ability to
block TNF--induced MMP (Figure 13). It is not known if the cleavage of MC163R full
length is required for its anti-apoptotic function in preventing mitochondrial membrane
permeabilization. Additional mutagenesis of these protease cleavage sites may yield clues
into the molecular mechanism of MC163R function.
Although The C-terminal domain contains no regions of homology to other
proteins it does interestingly contain potential BCL-2 homology (BH) domains (BH1-like
domain: a. a. 347-354, 383-399; BH2-like domain, a. a. 558-569; BH3-like domain: a. a.
345-355). Most viral proteins containing BH-like domains are not conserved in the amino
acid sequence. However, the viral protein maintains the required structural homology to
the cellular BH-containing proteins (Franklin & Khan 2013). The presence of BH-like
domains in MC163R might reveal a potential mechanism of function mimicking the antiapoptotic BcL-2 (Figure 17).
Poxviruses antagonize extrinsic cellular death signaling by competing with
receptors for ligands, preventing the activation of caspases, modulating reactive oxygen
(ROS) signals and dampening pro-apoptotic signals at the mitochondria (Pogo et al.
2004). MCV contains the death effector domain containing protein, MC159, which
blocks apoptotic signals at the death receptor as well as TNF--induced MMP (Murao &
Shisler 2005; Randall et al. 2012, Struzik et al. 2014; Figure 13). MC163 also blocked
TNF--induced MMP as shown utilizing the JC-1 stain as an indicator of mitochondrial
membrane potential (Figure 13). Whereas, MC159 binds FADD and procaspase-8 at the
receptor preventing the formation of the signalsome, the current data suggests MC163
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inhibits the extrinsic apoptotic pathway by at the level of the mitochondria, downstream
of the activation of caspase 8.
TNF- is a powerful pro-inflammatory cytokine that activates death pathways as
well as the activation of the NF-B transcription factor which plays a crucial role in the
activation of the pro-inflammatory response to viral infection. Viruses have adapted with
their host to antagonize the activation of NF-B at many points within the signal
pathway. Two MCV proteins, MC159 and MC160 attenuate NF-B activation through
interaction with the IKK complex, (Nichols & Shisler 2006; Nichols & Shisler 2009;
Randall et al. 2012; Struzik et al. 2014). Using a luciferase reporter assay under the
control of NF-B, cells transfected with pHA-MC159 or pHA-MC160 showed a
significant reduction in the activation of NF-B similarly to what has been previously
shown (Brady et al., 2015; Murao & Shisler 2005; Randall et al. 2012; Struzik et al.
2014; Nichols & Shisler 2006; Nichols & Shisler 2009). Interestingly, MC163R showed a
two-fold decrease in luciferase activity compared to cells transfected with empty vector
(Figure 14). Three MCV proteins, so far, have been shown to block NF-B activation
(MC132, MC159, and MC160). Due to the importance in NF-B signaling in the
antiviral response, it makes sense that MCV would have multiple proteins that are
capable of attenuating the activation of NF-B. This work is the first to characterize
MC163R and it would be too speculative to make any prediction as to the molecular
mechanism of action on NF-B activation.
Intrinsic activation of apoptosis arises through cellular damage (DNA damage,
ER stress) that lead to activation of pro-apoptotic signals converging at the mitochondria.
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CCCP is a protonophore that mimics mitochondrial damage and induces MMP and
subsequent apoptosis (de Graaf et al. 2004). MC163R blocked CCCP-induced MMP as
shown utilizing the JC-1 stain as an indicator of mitochondrial membrane potential
(Figure 16). Interestingly, BcL-2 overexpression has also been shown to block CCCP
induced MMP, but it not able to prevent m (de Graaf et al. 2004). MC163R contains
potential BH domains in the uncharacterized C-terminal region making it plausible that
MC163R could function to prevent MMP similarly to cBcL-2. Calcium regulation is an
important factor in apoptotic signaling. Calcium influx into the mitochondria can cause
the opening of the permeability transition pore (Gunter & Sheu 2009). An influx of
calcium into the mitochondria signals mitochondrial uncoupling and membrane
permeability transition pore (MPTP) opening. Blocking the MPTP opening by
Cyclosporin A (CsA) prevents CCCP-induced apoptosis. (Ganote & Armstrong 2003).
Interaction of the K7 protein from Kaposi’s sarcoma virus has been shown to prevent
apoptosis through the binding of the calcium-modulating cyclophilin ligand (CAML)
(Feng et al. 2002). Interestingly, the N-terminal MLS and TMD of MC163R has
homology to the region in K7 that is responsible for binding CAML (Figure 6C). These
data may lead to the discovery of the molecular mechanism for MMP protection by
MC163R. It is proposed that MC163 might function in modulating calcium signals at the
mitochondria, thus preventing apoptosis (Figure 17).
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Future Directions
This work is the first to identify a novel function for the previously
uncharacterized MC163 protein as a novel inhibitor of cellular apoptotic responses.
MC163R expression likely contributes to MCV pathogenesis by preventing cellular death
induced by viral stress during an MCV infection. Experiments are in progress to further
confirm the protective effect that MC163 has after stimulation with TNF- or CCCP. To
this end, a fluorescent protein called pBabe-puro-IMS-RP containing the localization
sequence of SMAC/Diablo will be utilized (pBabe-puro-IMS-RP was a gift from Peter
Sorger (Addgene plasmid # 24535) (Albeck et al. 2008). This protein will localize to the
inner-mitochondrial space and upon MMP will dissociate into the cytoplasm.
Additionally, experiments are planned to determine the degree that MC163 contributes to
MCV pathogenesis using a recombinant vaccinia virus expressing MC163 in a mouse
model.
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Figure 17: MC163R Model. The MC163 N-terminal region is proposed to modulate
calcium-induced apoptosis through the interaction of CAML or the MPTP. BcL-2
homology-like domains in the C-terminal region of MC163 are proposed to interact with
pro-apoptotic factors Bax or Bid and help to modulate apoptosis. Bid, BH3 interactingdomain death agonist; Bax, BCL-2 associated X protein; Cyt c, cytochrome c; BcL-2, Bcell lymphoma 2; CAML, calcium-modulating cyclophilin ligand; MPTP, mitochondrial
permeability transition pore
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